China: OOC and AI momentum, UCLA grants to advance human stem cell models, Curi Bio enters FDA’s ISTAND Program, SystImmune: FDA clearance for an IND using NAMs, and more

NAMs News

Actus des méthodes non-animales

SEPT. 28 - OCT. 02, 2026

China: OOC and AI momentum, UCLA grants to advance human stem cell models, Curi Bio enters FDA’s ISTAND Program, SystImmune: FDA clearance for an IND using NAMs, and more
Donate